Literature DB >> 12719564

Determination of infectious retrovirus concentration from colony-forming assay with quantitative analysis.

Young Jik Kwon1, Gene Hung, W French Anderson, Ching-An Peng, Hong Yu.   

Abstract

The colony formation assay is the most commonly used titration method for defining the concentration of replication-incompetent murine leukemia virus-derived retroviral vectors. However, titer varies with target cell type and number, transduction time, and concentration of polycation (e.g., Polybrene). Moreover, because most of the viruses cannot encounter target cells due to Brownian motion, their short half-lives, and the requirement for target cell division for activity, the actual infectious retrovirus concentration in the collected supernatant is higher than the viral titer. Here we correlate the physical viral particle concentration with the infectious virus concentration and colony formation titer with the help of a mathematical model. Ecotropic murine leukemia retrovirus supernatant, collected from the GP+E86/LNCX retroviral vector producer cell line, was concentrated by centrifugation and further purified by a sucrose density gradient. The physical concentration of purified viral vectors was determined by direct particle counting with an electron microscope. The concentrations of fresh and concentrated supernatant were determined by a quantitative reverse transcriptase activity assay. Titration of all supernatants by neomycin-resistant colony formation assay was also performed. There were 767 +/- 517 physical viral particles per infectious CFU in the crude viral supernatant. However, the infectious viral concentration determined by mathematical simulation was 143 viral particles per infectious unit, which is more consistent with the concentration determined by particle counting in purified viral solution. Our results suggest that the mathematical model can be used to extract a more accurate and reliable concentration of infectious retrovirus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719564      PMCID: PMC154030          DOI: 10.1128/jvi.77.10.5712-5720.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection.

Authors:  D G Miller; M A Adam; A D Miller
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

2.  Binding kinetics of ecotropic (Moloney) murine leukemia retrovirus with NIH 3T3 cells.

Authors:  H Yu; N Soong; W F Anderson
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

3.  Improved methods of retroviral vector transduction and production for gene therapy.

Authors:  H Kotani; P B Newton; S Zhang; Y L Chiang; E Otto; L Weaver; R M Blaese; W F Anderson; G J McGarrity
Journal:  Hum Gene Ther       Date:  1994-01       Impact factor: 5.695

4.  Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein.

Authors:  J L Battini; P Rodrigues; R Müller; O Danos; J M Heard
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

5.  Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapy.

Authors:  K L March; J E Madison; B C Trapnell
Journal:  Hum Gene Ther       Date:  1995-01       Impact factor: 5.695

6.  Plasma membrane receptors for ecotropic murine retroviruses require a limiting accessory factor.

Authors:  H Wang; R Paul; R E Burgeson; D R Keene; D Kabat
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

7.  Cell fusion induced by the murine leukemia virus envelope glycoprotein.

Authors:  J S Jones; R Risser
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

8.  In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.

Authors:  R L Willey; D H Smith; L A Lasky; T S Theodore; P L Earl; B Moss; D J Capon; M A Martin
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

9.  Disulfide bonding controls the processing of retroviral envelope glycoproteins.

Authors:  B C Gliniak; S L Kozak; R T Jones; D Kabat
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

10.  Evidence that retroviruses integrate into post-replication host DNA.

Authors:  M Hajihosseini; L Iavachev; J Price
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

View more
  24 in total

1.  Multilineage differentiation of dental follicle cells and the roles of Runx2 over-expression in enhancing osteoblast/cementoblast-related gene expression in dental follicle cells.

Authors:  K Pan; Q Sun; J Zhang; S Ge; S Li; Y Zhao; P Yang
Journal:  Cell Prolif       Date:  2010-06       Impact factor: 6.831

2.  Expression and immunological analysis of capsid protein precursor of swine vesicular disease virus HK/70.

Authors:  Hong Tian; Jing-yan Wu; You-jun Shang; Shuang-hui Ying; Hai-xue Zheng; Xiang-tao Liu
Journal:  Virol Sin       Date:  2010-06-06       Impact factor: 4.327

3.  Efficiency of human immunodeficiency virus type 1 postentry infection processes: evidence against disproportionate numbers of defective virions.

Authors:  James A Thomas; David E Ott; Robert J Gorelick
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

4.  Rapid dissociation of HIV-1 from cultured cells severely limits infectivity assays, causes the inactivation ascribed to entry inhibitors, and masks the inherently high level of infectivity of virions.

Authors:  Emily J Platt; Susan L Kozak; James P Durnin; Thomas J Hope; David Kabat
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

5.  Viral dynamics during primary simian immunodeficiency virus infection: effect of time-dependent virus infectivity.

Authors:  Naveen K Vaidya; Ruy M Ribeiro; Christopher J Miller; Alan S Perelson
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

6.  Overexpression of the PLAP-1 gene inhibits the differentiation of BMSCs into osteoblast-like cells.

Authors:  Jing Sun; Ting Zhang; Panpan Zhang; Linlin Lv; Yanzhi Wang; Jing Zhang; Shu Li
Journal:  J Mol Histol       Date:  2014-07-20       Impact factor: 2.611

7.  Optical manipulation of a single human virus for study of viral-cell interactions.

Authors:  Ximiao Hou; Michael C DeSantis; Chunjuan Tian; Wei Cheng
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2016-09-16

8.  Basis for early and preferential selection of the E138K mutation in HIV-1 reverse transcriptase.

Authors:  Matthew McCallum; Maureen Oliveira; Ruxandra-Ilinca Ibanescu; Victor G Kramer; Daniela Moisi; Eugene L Asahchop; Bluma G Brenner; P Richard Harrigan; Hongtao Xu; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2013-07-15       Impact factor: 5.191

9.  Effects of core binding factor alpha1 or bone morphogenic protein-2 overexpression on osteoblast/cementoblast-related gene expressions in NIH3T3 mouse cells and dental follicle cells.

Authors:  K Pan; S Yan; S Ge; S Li; Y Zhao; P Yang
Journal:  Cell Prolif       Date:  2009-04-24       Impact factor: 6.831

10.  N-cadherin knock-down decreases invasiveness of esophageal squamous cell carcinoma in vitro.

Authors:  Ke Li; Wei He; Na Lin; Xin Wang; Qing-Xia Fan
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.